1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €11.32 (+33.96%). The median is €11.32 (+33.96%).
| Buy |
4 |
| Hold |
7 |
| Sell |
2 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 552.01k | 96.30% |
| Gross profit | 384.66k | 97.34% |
| Net profit | -4.24m | 309.15% |
| EBITDA | -4m | 231.18% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €76.05m |
Number of shares | 9.01m |
52-week high/low | €16.68 - €3.41 |
| Dividends | No |
Beta | 0.09 |
P/E ratio | -8.21 |
PEG ratio | 0.06 |
P/B ratio | -3.94 |
P/S ratio | 14.10 |
Company profile
| Name | Atara Biotherapeutics Inc |
| CEO | Anhco Nguyen |
| Employees | 10 |
